Italian and Swedish researchers win richest Swiss science prize
An immunologist and a vascular biologist were recipients of the prize
Keystone
This content was published on
2 minutes
SDA-ATS/ac
The Louis-Jeantet Prize for Medicine has been awarded to Antonio Lanzavecchia from the Swiss-Italian University and Christer Betsholtz from the University of Uppsala in Sweden. They will each receive CHF700,000 ($728,221), of which CHF625,000 must be spent on research.
Established in 1986, the prize recognises excellence in European biomedical research. The main fields covered include physiology, biophysics, structural biology, biochemistry, cellular and molecular biology, developmental biology and genetics. Only researchers active in the Council of EuropeExternal link member countries are eligible for the prize.
Lanzavecchia, an immunologist and director of the Institute for Biomedicine Research in Bellinzona, won for his contribution to the understanding of the immune response in humans, and for the detection of antibodies that effectively neutralise various infectious agents.
According to the Louis-Jeantet Foundation, he will use the prize money to continue his research on the characterisation of the mechanism for antibody diversification.
The other winner, Betsholtz, is also the director of the Director of the Karolinska Institute’s Integrated Cardio Metabolic Centre in Stockholm, Sweden. He has been recognised for his fundamental discoveries in vascular biology, including the characterisation of specialised cells – pericytes – and their role in vascular development and permeability. Betsholtz will use the prize money to continue the study of blood vessels in the central nervous system and to better understand their role in normal and pathological processes.
The awards ceremony will take place on April 25 in Geneva. Since its inception, the Louis-Jeantet Prize has been awarded to 90 researchers, including 16 from Switzerland. Ten of them were subsequently awarded the Nobel Prize for Medicine or Chemistry.
The Louis-Jeantet Foundation, created in 1982, is the legacy of Louis Jeantet, a Geneva-based French businessman who made his fortune in the automotive industry. Its mission is to advance medicine and it annually grants around CHF4.2 million to support biomedical research.
Popular Stories
More
Banking & Fintech
UBS releases ‘hundreds’ of staff in fresh wave of job cuts
As a Swiss Abroad, how do you feel about the emergence of more conservative family policies in some US states?
In recent years several US states have adopted more conservative policies on family issues, abortion and education. As a Swiss citizen living there, how do you view this development?
‘Confederation is a subsidy machine’: Swiss finance minister
This content was published on
The Swiss government is a machine for distributing subsidies to various actors in the country, says finance minister Karin Keller-Sutter.
Lack of funds ends third bid to salvage Säntis ship from Swiss lake
This content was published on
A third attempt to salvage the steamship Säntis, lying at the bottom of Lake Constance in Switzerland since 1933, has failed before it has even begun.
Nestlé Waters on trial in France over illegal waste dumps
This content was published on
Bottled water producer Nestlé Waters to stand trial, accused of illegally dumping waste and maintaining unauthorised dumps.
Swiss army chiefs defend botched procurement projects
This content was published on
Swiss defense Minister and military heads defend against parliamentary and media criticisms of problematic procurement projects.
Swiss cheese exports recorded second-best year in 2024
This content was published on
A total 79,268 tons of Swiss cheese worth CHF748.5 million was exported abroad in 2024 - a 7.9% increase in annual sales from the previous year.
This content was published on
Insects benefit from storm devastation, says a 20-year study by the Swiss Federal Institute for Forest, Snow and Landscape Research.
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.
Read more
More
How to solve the crisis of science
This content was published on
A leading public health expert tells swissinfo.ch how modern science can be put back on track for the greater good of society.
This content was published on
Nina Kathe has just started classes at the University of Zurich, but she’s already the author of award-winning research into a global health concern.
This content was published on
When Albert Einstein lived in Zurich, he used to prepare the groundwork for his revolutionary theories while sitting in a café. Many other Nobel Prize winners chose to spend time in the city for work, as an exhibition shows. A past laureate takes a guess at why.
Will exclusive collaborations yield more drug breakthroughs?
This content was published on
Recently FDA-approved, Novartis's pioneering immunotherapy was developed through an agreement with University of Pennsylvania researchers.
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.